drugset / Trial / NCT05756647

Mandibular Advancement vs Home Treatment for Primary Snoring

NCT05756647

Phase 2 Completed 100 enrolled Washington University School of Medicine
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomized controlled trial for non-apneic snorers. The primary goal of the study is to evaluate the efficacy of a mandibular advancement device (MAD) vs conservative treatment for adults with non-apneic snoring as measured by the partners report of response to treatment (CGI-I). The secondary goal is to evaluate the effectiveness of treatment of snoring on the Epworth Sleepiness Scale (ESS), a modified Symptoms of Nocturnal Obstruction and Related Events (SNORE-25) questionnaire, the Pittsburgh Sleep Quality Index (PSQI), and the Clinical Global Impression of Severity Scale (CGI-S)

Timeline

Start
2022-11-07
Primary completion
2023-07-03
Completion
2023-07-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mometasone Other / unclassified Intranasal

Indications

No indication recorded.